Anzeige
Mehr »
Samstag, 14.06.2025 - Börsentäglich über 12.000 News
Von SOL zu BTC: Pioneer aktiviert automatisierte Bitcoin-Treasury über Kora AI Beta
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JKVH | ISIN: IE00B56GVS15 | Ticker-Symbol: 8AK
Tradegate
13.06.25 | 16:45
26,000 Euro
+0,78 % +0,200
1-Jahres-Chart
ALKERMES PLC Chart 1 Jahr
5-Tage-Chart
ALKERMES PLC 5-Tage-Chart
RealtimeGeldBriefZeit
25,60026,00013:02
25,60026,00013.06.

Aktuelle News zur ALKERMES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiRBC Capital behält Alkermes-Aktienbewertung trotz Sicherheitsbedenken bei2
MoAlkermes bei Goldman Sachs Healthcare: Strategische Schritte bei Schlafstörungen2
02.06.Alkermes plc: Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference207DUBLIN, June 2, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat presentation at the Goldman Sachs 46th Annual Global Healthcare...
► Artikel lesen
02.06.Alkermes plc: Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences206- Multiple Subgroup Analyses Presented From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan), Including Data on Lipid and Glycemic Profiles - DUBLIN, June 2, 2025 /PRNewswire/...
► Artikel lesen
ALKERMES Aktie jetzt für 0€ handeln
29.05.Alkermes plc: Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025245- Company to Present Eight Posters and Two Oral Presentations, Including New Analyses From ALKS 2680 Phase 1 Study - - New Research Evaluating the Clinical, Economic and Humanistic Burden...
► Artikel lesen
28.05.Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)1
21.05.Alkermes plc. - 8-K, Current Report1
14.05.Stifel maintains Alkermes stock Buy rating, $42 target2
12.05.Cantor Fitzgerald maintains $43 target on Alkermes stock1
04.05.Alkermes plc (ALKS): Among Billionaire Jim Simons' RenTech's Small-Cap Stock Picks with Huge Upside Potential1
02.05.Alkermes' Q1 Earnings and Revenues Fall Short of Estimates1
01.05.Stifel maintains Alkermes stock Buy rating, $42 target post-earnings1
01.05.Alkermes Plc Reports Drop In Q1 Bottom Line245WASHINGTON (dpa-AFX) - Alkermes plc (ALKS) reported earnings for first quarter that decreased from the same period last yearThe company's earnings came in at $22.46 million, or $0.13 per share....
► Artikel lesen
01.05.Alkermes GAAP EPS of $0.13 beats by $0.08, revenue of $306.5M beats by $2.39M6
01.05.Alkermes plc Reports First Quarter 2025 Financial Results221- First Quarter Revenues of $306.5 Million - - GAAP Net Income of $22.5 Million and Diluted GAAP Earnings per Share of $0.13 - - Company Reiterates 2025 Financial Expectations...
► Artikel lesen
01.05.Alkermes plc. - 8-K, Current Report4
30.04.Alkermes Q1 2025 Earnings Preview1
30.04.Alkermes plc: New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)234- Survey Respondents Reported That AUD Diagnosis and Decision to Seek Treatment Were Driven by Negative Consequences of Drinking - - Respondents Cited the Influence of Their Healthcare...
► Artikel lesen
29.04.Beyond The Numbers: 6 Analysts Discuss Alkermes Stock1
22.04.Alkermes stock holds Buy rating with $27 target from TD Cowen2
Weiter >>
63 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1